CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand

  • April 2018 •
  • 117 pages •
  • Report ID: 5399423 •
  • Format: PDF
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand

Summary
New Zealand is a mature healthcare market with a strong regulatory environment.The largest and fastest growing segment of biologics is monoclonal antibodies, which accounts for around $110m per annum.

It spends approximately 11% of its GDP on healthcare.In 2015, the pharmaceutical sales declined to around $688m from around $796m in 2014.

This again rose to around $746 in 2016.The market is forecast to grow to and cross $1 billion in 2022; at a CAGR of around 6%.

In 2010, the medical device market in New Zealand was worth about $1.17 billion, which increased to around $1.4 billion in 2017. It is expected to grow at a CAGR of about 3.4% from around $1.5 billion in 2018 to $1.8 billion in 2022.

The main segments were ophthalmic devices, wound care management, healthcare IT, orthopedic devices and in vitro diagnostics.The increasing elderly population and high investment in R&D expenditure are expected to drive the growth of pharmaceutical market.

However, high penetration of generics in the market and the policies of PHARMAC, pose as a barrier for the multinational pharmaceutical manufacturers

The government of New Zealand encourages innovation and supports biomedical and drug development research with continuous investment in science, research and technology as a mechanism to increase the knowledge economy.

The report "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand", provides information on the healthcare, regulatory, and reimbursement landscape in New Zealand, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Douglas, Mylan, GSK, Merck and NZP) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, DePuy Synthes, Essilor and Fisher & Paykel Healthcare)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of New Zealand
- Porter’s five forces analysis for pharmaceutical and medical devices market of New Zealand
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the New Zealand healthcare market

Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in New Zealand, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Douglas, Mylan, GSK, Merck and NZP) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, DePuy Synthes, Essilor and Fisher & Paykel Healthcare)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of New Zealand
- Porter’s five forces analysis for pharmaceutical and medical devices market of New Zealand
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the New Zealand healthcare market.

Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the New Zealand healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the New Zealand healthcare market.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.